Post-approval studies (Phase 4)Study completedNCT00474955
What this trial is testing
PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure.
Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 27